GlassScriptPhysician profile
Melhem R Ghaleb
NPI 1043201627
$117,800.97
in general payments reported to CMS, 2019-2025
21 companies · $50K in 2025
The $50K reported for 2025 was more than what 97% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $20.50 · 2021: $668 · 2022: $11K · 2023: $29K · 2024: $27K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Travel and Lodging: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $16K · Honoraria: $5,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,863.11 |
| Travel and Lodging | $25,943.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,425.00 |
| Food and Beverage | $15,750.08 |
| Honoraria | $5,382.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $29,914.39 | 2021-2025 | In.Pact Admiral, Mvp, Riptide |
| Penumbra, INC. | $28,051.55 | 2021-2025 | Indigo System, Penumbra Coil 400, Penumbra System |
| Terumo Medical Corporation | $23,754.93 | 2019-2025 | Azur Cx Detachable, Glidesheath Slender |
| Stryker Corporation | $13,126.44 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Inari Medical, INC. | $13,109.02 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Argon Medical Devices, INC. | $5,704.56 | 2025 | Clot Management |
| Nevro Corp. | $1,948.99 | 2024 | Senza |
| Boston Scientific Corporation | $313.51 | 2022-2025 | Eluvia, General - Vascular Intervention, General - Thrombectomy |
| Globus Medical, INC. | $303.00 | 2025 | Senza |
| Angiodynamics, INC. | $235.86 | 2021-2023 | Xcela |
| Siemens Medical Solutions USA, INC. | $231.42 | 2024-2025 | Embozene, Microthermx Microwave Ablation System |
| W. L. Gore & Associates, INC. | $206.39 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo, Viatorr Endoprosthesis |
| Endologix LLC | $196.43 | 2023 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Philips North America LLC | $190.92 | 2023-2024 | (Br5) Peripheral Ivus |
| Bolton Medical INC | $103.58 | 2025 | Treo Abdominal Stent-Graft System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $101.15 | 2023 | Cardiva Vascade 6/7f Vcs |
| Thrombolex, INC. | $100.29 | 2025 | Bashir Endovascular Catheter |
| Edwards Lifesciences Corporation | $97.85 | 2023 | |
| Becton, Dickinson and Company | $48.11 | 2025 | Lifestream |
| Novartis Pharmaceuticals Corporation | $41.15 | 2024 | |
| Ge Healthcare | $21.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$281.25 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melhem Ghaleb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.